Back to search

United Kingdom· GB-APID-4769611000001107

Fibrogammin 250unit powder and solvent for solution for injection vials

A medicinal product containing factor xiii, registered in United Kingdom by CSL Behring UK Ltd.

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedFibrogammin 250unit powder and solven…ATC—REGISTER NO.GB-APID-4769611000001…PACKS LISTED1CHECKEDOctober 2, 2026

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Factor XIII
Manufacturer
CSL Behring UK Ltd
Country
United Kingdom (GB)
ATC code
—
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
October 2, 2026

Packs & prices · 1

  • gtin
    5028360000312

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/44649a32-ff53-406d-bbc6-fa1158163235
GET /v1/drugs/44649a32-ff53-406d-bbc6-fa1158163235?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "4769611000001107",
  "desc": "Fibrogammin 250unit powder and solvent for solution for injection vials (CSL Behring UK Ltd)",
  "form": "Powder and solvent for solution for injection",
  "vpid": "36066411000001108",
  "source": "dmd",
  "vtm_id": "775331003",
  "strength": "250 unit",
  "substance": "Factor XIII",
  "ingredient": "Factor XIII",
  "supplier_code": "9364911000001100"
}

See everything about factor xiii.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.